NMR Profile Advantage Position LipoScience as the provider of a scalable, FDA-cleared NMR-based LipoProfile test and automated Vantera analyzer to drive personalized cardiovascular risk management for laboratories seeking advanced lipid profiling.

Clinical Laboratory Rollout Target national and regional clinical laboratories for deployment of the Vantera Clinical Analyzer to enable walk-away automation and ease of use, unlocking volume-based sales through LIS/EHR integrations and service contracts.

High Impact Outcomes Highlight potential to reduce cardiovascular risk assessment time and improve patient stratification by measuring LDL particle number, appealing to physicians and payers seeking better outcomes and cost-effective management strategies.

Market Momentum Leverage the track record of over 10 million LipoProfile tests ordered to demonstrate adoption momentum and build credibility with hospitals, labs, and regional health networks aiming to expand precision diagnostics offerings.

Scalable Revenue Emphasize revenue opportunities from multiple streams—instrument sales or leases, per-test reagents or consumables, maintenance, and potential managed services—appropriate for mid-sized to large lab customers in the cardiovascular diagnostics space.